Catalyst Wire Dossier Catalyst Wire Dossier

RSV vaccine candidate

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSV vaccine candidate, covering 2022-02-25 to 2022-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults [Phase 1]

See pricing